Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 542-542
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 59
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1143-1143
Open Access | Times Cited: 53
Polymeric micelles: A novel drug delivery system for the treatment of breast cancer
Aiswarya Chaudhuri, Korra Ramesh, Dulla Naveen Kumar, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 77, pp. 103886-103886
Closed Access | Times Cited: 52
Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
Aiswarya Chaudhuri, Dulla Naveen Kumar, Rasheed A. Shaik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10068-10068
Open Access | Times Cited: 51
Cancer stem cells and their niche in cancer progression and therapy
Qiuping Liu, Zongliang Guo, Guoyin Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises
Javed Ahmad, Javed Ahamad, Mohammed S. Algahtani, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 2, pp. 229-244
Closed Access | Times Cited: 9
Functionalized siRNA-chitosan nanoformulations promote triple-negative breast cancer cell death via blocking the miRNA-21/AKT/ERK signaling axis: in-silico and in vitro studies
Shaymaa A. Abdulmalek, Abdulrahman M. Saleh, Yasmin R. Shahin, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6941-6962
Open Access | Times Cited: 8
A biomimetic camouflaged metal organic framework for enhanced siRNA delivery in the tumor environment
Tongxiang Tao, Sajid Ur Rehman, Shuai Xu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4080-4096
Closed Access | Times Cited: 7
An Investigation of In Vitro Anti-Cancer Efficacy of Dihydroartemisinin-Loaded Bovine Milk Exosomes Against Triple-Negative Breast Cancer
Dulla Naveen Kumar, Aiswarya Chaudhuri, Udita Shiromani, et al.
The AAPS Journal (2024) Vol. 26, Iss. 5
Closed Access | Times Cited: 6
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2661-2661
Open Access | Times Cited: 16
AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers
Gowri Palanissami, Solomon F.D. Paul
Exploration of Targeted Anti-tumor Therapy (2023), pp. 812-849
Open Access | Times Cited: 16
Thermosusceptible Nitric-Oxide-Releasing Nitrogel for Strengthening Antitumor Immune Responses with Tumor Collagen Diminution and Deep Tissue Delivery during NIR Laser-Assisted Photoimmunotherapy
Adityanarayan Mohapatra, Jagannath Mondal, Padmanaban Sathiyamoorthy, et al.
ACS Applied Materials & Interfaces (2023)
Closed Access | Times Cited: 13
Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer
Ye Cao, Fansu Meng, Tiange Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 5
Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer
Risav Banerjee, Indrajit Maitra, T. Bhattacharya, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104417-104417
Closed Access | Times Cited: 5
Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach
Aiswarya Chaudhuri, Dulla Naveen Kumar, Saurabh Kumar Srivastava, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 926-926
Open Access | Times Cited: 5
Peptide-Modified Cyclodextrin-Based Nanosystem for Co-Delivery of Celastrol and siPD-L1 to Tumors
Dongna Wang, Tianyu Zhang, Yixue Hu, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 10, pp. 11432-11444
Closed Access | Times Cited: 4
Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024
Hongyi Liang, Guoliang Yin, Dandan Feng, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 4
Knockdown of miR-182 changes the sensitivity of triple-negative breast cancer cells to cisplatin
Halil Dönmez, Bahadır Batar, Burhan Turgut
Nucleosides Nucleotides & Nucleic Acids (2025), pp. 1-15
Closed Access
Exploring Combinations of Dihydroartemisinin for Cancer Therapy: A Comprehensive Review
K. Usha Rani, Rohan Chand Sahu, Aiswarya Chaudhuri, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 765, pp. 151854-151854
Closed Access
Drug Delivery System for Cancer Immunotherapy: Potential Roles, Challenge and Recent Advances
Zi-Yue Lin, Qian Song, Kai Xu
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer
Ruoyi Wang, Xu Huang, Xiaoxi Chen, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 6, pp. 3568-3598
Open Access | Times Cited: 3
Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor
Rui Han, Hongxing Yang, Changquan Ling, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Self‐Promoted Targeting Delivery of Nanodrug Through Chemotherapeutic Upregulation of CD47 for Triple Negative Breast Cancer Therapy
Qianqian Liu, Xiayun Chen, Yong Jiang, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 13
Closed Access | Times Cited: 6
The Influence of the Sizes of Nanodiamond Aggregates in Suspensions on the Efficiency of Sorption of 90Y and 177Lu Isotopes for Further Use in Nuclear Medicine
A. G. Kazakov, J. S. Babenya, T. Y. Ekatova, et al.
Radiochemistry (2024) Vol. 66, Iss. 2, pp. 198-205
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top